High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study-Reference-Cited by-同舟云学术

High dose hepatitis B vaccine is not effective in patients using immunomodulatory drugs: a pilot study

Published:2019-03-19 Issue:5 Volume:15 Page:1177-1182
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Haykir Solay Asli¹^ORCID,Eser Fatma¹^ORCID

Affiliation:

1. Infection Disease and Clinical Microbiology Department, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey

Funder

no financial support

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2019.1574151

Reference27 articles.

1. The impact of immunogenicity of TNFα inhibitors in autoimmune inflammatory disease. A systematic review and meta-analysis

2. Ustekinumab

3. Hepatitis B vaccine nonresponders

4. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Panel Consensus Statements on Vaccination for Adults with AIRD in India;Indian Journal of Rheumatology;2024-09-04

2. Efficacy of Vaccination and Revaccination Against Hepatitis B Virus Using 2 Different Strategies in Patients With Inflammatory Bowel Disease;Inflammatory Bowel Diseases;2024-08-05

3. Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort;European Journal of Pediatrics;2024-07-18

4. The immunogenicity of hepatitis B vaccine in psoriasis patients and by treatment type: A retrospective cohort study;Journal of the European Academy of Dermatology and Venereology;2024-06-10

5. Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation;Journal of the American Academy of Dermatology;2024-06